Literature DB >> 10319884

Status epilepticus in children with newly diagnosed epilepsy.

A T Berg1, S Shinnar, S R Levy, F M Testa.   

Abstract

Status epilepticus (SE) constitutes a neurological emergency and may be of prognostic value in individuals with epilepsy. Little is known about the associations between other prognostic factors in epilepsy and the occurrence of SE. The following study examines associations between clinical characteristics of children with newly diagnosed epilepsy and the occurrence of SE when epilepsy is first diagnosed. Children were recruited prospectively from the practices of physicians throughout Connecticut. Information was collected via standardized interviews with parents and review of pertinent records. Analyses were performed for any SE, unprovoked SE only, and previous provoked SE. Of 613 children, 56 (9.1%) had one or more episodes of SE by the time the diagnosis of epilepsy was established. Factors correlated with SE during an unprovoked seizure were partial seizures and previous craniotomy. For SE during a provoked seizure, correlates were primarily young age at onset of epilepsy and nonidiopathic epilepsy syndrome. To date, subsequent SE has occurred in 4.3% of children without and in 19.6% of those with SE at diagnosis. By the time epilepsy is first diagnosed in children, SE has already occurred in a substantial minority. It is correlated with specific clinical characteristics in the children, which differ depending on whether the SE was provoked or unprovoked. SE has a high risk of recurring.

Entities:  

Mesh:

Year:  1999        PMID: 10319884     DOI: 10.1002/1531-8249(199905)45:5<618::aid-ana10>3.0.co;2-3

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

Review 1.  A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus.

Authors:  Francesco Brigo; Raffaele Nardone; Frediano Tezzon; Eugen Trinka
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

2.  Management of pediatric status epilepticus.

Authors:  Nicholas S Abend; Tobias Loddenkemper
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

3.  Status epilepticus in Indian children in a tertiary care center.

Authors:  Sheffali Gulati; Veena Kalra; M R Sridhar
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

4.  Prospective study of new-onset seizures presenting as status epilepticus in childhood.

Authors:  R K Singh; S Stephens; M M Berl; T Chang; K Brown; L G Vezina; W D Gaillard
Journal:  Neurology       Date:  2010-01-20       Impact factor: 9.910

5.  Convulsive status epilepticus and health-related quality of life in children with epilepsy.

Authors:  Mark A Ferro; Richard F M Chin; Carol S Camfield; Samuel Wiebe; Simon D Levin; Kathy N Speechley
Journal:  Neurology       Date:  2014-07-18       Impact factor: 9.910

6.  Yield of emergent neuroimaging in children with new-onset seizure and status epilepticus.

Authors:  Todd W Lyons; Kara B Johnson; Kenneth A Michelson; Lise E Nigrovic; Tobias Loddenkemper; Sanjay P Prabhu; Amir A Kimia
Journal:  Seizure       Date:  2015-12-25       Impact factor: 3.184

Review 7.  Pediatric status epilepticus management.

Authors:  Nicholas S Abend; Tobias Loddenkemper
Journal:  Curr Opin Pediatr       Date:  2014-12       Impact factor: 2.856

Review 8.  Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.

Authors:  Mario Mastrangelo; Andrea Celato
Journal:  World J Pediatr       Date:  2012-05-10       Impact factor: 2.764

Review 9.  Status epilepticus and refractory status epilepticus management.

Authors:  Nicholas S Abend; David Bearden; Ingo Helbig; Jennifer McGuire; Sona Narula; Jessica A Panzer; Alexis Topjian; Dennis J Dlugos
Journal:  Semin Pediatr Neurol       Date:  2014-12-12       Impact factor: 3.042

10.  Prognostic factors of status epilepticus in children.

Authors:  Du Cheol Kang; Young-Mock Lee; JoonSoo Lee; Heung Dong Kim; ChangJun Coe
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.